REGULATORY COMPLIANCE – Page 23

Shared user credentials during internal audit – evidence package for inspectors

Identifying early signals of shared user credentials misuse can prevent escalation into more significant data integrity issues. Look for the following symptoms:Click to read the full article.

Audit trail gaps identified during FDA inspection – evidence package for inspectors

Managing Audit Trail Gaps Found During FDA Inspections: An Actionable Playbook In the evolving landscape of pharmaceutical manufacturing and quality control, audit trail gaps during FDA inspections have become a…

Repeat data integrity lapses during internal audit – 483 risk assessment

Identifying signs of potential data integrity lapses is crucial for timely mitigation. Here are several common symptoms that may indicate underlying problems:Click to read the full article.

Manual data transcription without verification during data review – 483 risk assessment

Identifying potential data integrity issues early can prevent larger compliance problems. Symptoms associated with improper manual data transcription include:Click to read the full article.

Audit trail gaps identified during FDA inspection – CAPA effectiveness checks

Identifying audit trail gaps often starts with recognizing symptoms on the manufacturing floor or in the quality laboratory. Common signals include:Click to read the full article.

Audit trail gaps identified during data review – remediation roadmap regulators expect

Identifying audit trail gaps early is crucial. Symptoms can manifest in various forms across the production and quality sectors:Click to read the full article.

Unsecured raw data storage during system validation – CAPA effectiveness checks

Identifying early signals of unsecured raw data storage is crucial to mitigate risks effectively. Symptoms may vary by department but generally include:Click to read the full article.

Shared user credentials during internal audit – remediation roadmap regulators expect

Identifying the symptoms associated with shared user credentials is crucial for timely intervention. Common signs include:Click to read the full article.

Inadequate DI governance during data review – 483 risk assessment

Identifying signals indicative of inadequate data governance is crucial. Symptoms may appear in various forms:Click to read the full article.

Shared user credentials during laboratory walkthrough – remediation roadmap regulators expect

Identifying symptoms of shared user credentials misuse is the first step toward remediation. Common signals include:Click to read the full article.

Unsecured raw data storage during FDA inspection – CAPA effectiveness checks

Identifying symptoms related to unsecured raw data is the first step in maintaining data integrity. Common signals include:Click to read the full article.

Repeat data integrity lapses during laboratory walkthrough – remediation roadmap regulators expect

Observing real-time indicators that suggest lapses in data integrity is crucial for any quality-focused organization. Signs to watch for during laboratory walkthroughs include:Click to read the full article.